Combined Use of Anticancer Drugs and an Inhibitor of Multiple Drug Resistance-Associated Protein-1 Increases Sensitivity and Decreases Survival of Glioblastoma Multiforme Cells In Vitro

MRP3: a molecular target for human glioblastoma multiforme immunotherapy.

(2010) Chien-Tsun Kuan et al.   BMC CANCER

Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma

(2010) Michael Brada et al.   JOURNAL OF CLINICAL ONCOLOGY

Influence of blood-brain barrier efflux pumps on the distribution of vincristine in brain and brain tumors

(2010) F. Wang et al.   NEURO-ONCOLOGY

Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1®

(2008) Robert W. Robey et al.   BIOCHEMICAL PHARMACOLOGY

Effect of Tacrolimus on Activity and Expression of P-Glycoprotein and ATP-Binding Cassette Transporter A5 (ABCA5) Proteins in Hematoencephalic Barrier Cells

(2008) Claudia Andrea Quezada et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Strategies to Overcome or Circumvent P-Glycoprotein Mediated Multidrug Resistance

(2008) Xun Li et al.   CURRENT MEDICINAL CHEMISTRY

Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity

(2008) Monika E. Hegi et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of Hypoxia-inducible Factor-1α Silencing on the Sensitivity of Human Brain Glioma Cells to Doxorubicin and Etoposide

(2008) Lei Chen et al.   NEUROCHEMICAL RESEARCH

ABC multidrug transporters: structure, function and role in chemoresistance

(2007) Frances J Sharom   PHARMACOGENOMICS